CV SCIENCES INC by CV Sciences, Inc. CVSI:OTCQB OTCQB
Early-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process.

{{ portfolio.portfolio_name }}
You have no watchlists at this time, click "Manage watchlists" to create your first watchlist.
Manage watchlists

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

3.190 -0.005 (-0.16%)

After Hours 3.16 (%)

Data as of Aug 17, 2019

Prev. Close 3.195
Price Open 3.21
Volume 583,415
Day's Range 3.12 - 3.22
52 Wk Range 2.76 - 9.2
50 Day Moving Avg.
PE Ratio 0
Shares Outstanding 99.23M
Market Cap 316.55M

Trade CVSI stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

Date	Research Firm	Action	Current	Target
8/13/19		Initiates Coverage On	Overweight	5.0
5/16/19		Initiates Coverage On	Buy	9.0

Piper Jaffray Initiates Coverage Of Cronos, Says Stock 'Warrants A Premium Valuation' Wayne DugganTue, 13 Aug 2019 14:06:16 -0400
Benzinga's Top Upgrades, Downgrades For August 13, 2019 Lisa LevinTue, 13 Aug 2019 09:46:57 -0400
Piper Jaffray Initiates Coverage On CV Sciences with Overweight Rating, Announces $5 Price Target Benzinga_NewsdeskTue, 13 Aug 2019 07:44:02 -0400
CV Sciences Q2 EPS $0.01 Misses $0.02 Estimate, Sales $16.9M Miss $17.45M Estimate Benzinga NewsdeskTue, 06 Aug 2019 16:03:27 -0400
The Week Ahead In Cannabis: Cronos And GW Pharma Earnings, Ontario's Second License Lottery Alex OleinicMon, 05 Aug 2019 08:13:29 -0400
The Week In Cannabis: A New Global Leader, Moves In UK And Colombia, ETFs Outperform Javier HasseSun, 21 Jul 2019 14:31:47 -0400
The Most Actively Traded Securities On OTC Markets In June Spencer IsraelThu, 18 Jul 2019 09:16:05 -0400
The Week In Cannabis: House Takes Historic Vote, New York Decriminalizes, Woman-Led Company Lists On Nasdaq, And More Javier HasseSun, 23 Jun 2019 15:12:26 -0400
The Week In Cannabis: Colorado Hits $1B In Sales, Harborside In Canada, Kroger Embraces CBD, And More Javier HasseSun, 16 Jun 2019 09:11:45 -0400
CV Sciences Announces Supplier Deal With Kroger, Expands Topical Offerings Alex OleinicWed, 12 Jun 2019 14:25:45 -0400
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

CV Sciences, Inc. CEO Issues Letter to Shareholders Globe Newswire5 days ago
CV Sciences, Inc. Reports Second Quarter 2019 Financial Results Globe NewswireAug 06, 2019
CV Sciences, Inc. Announces Expanded Distribution Partnership With The Kroger Co. Globe NewswireJul 30, 2019
CV Sciences, Inc. Applauds Ohio's State Law Passage of Senate Bill 57 Globe NewswireJul 30, 2019
U.S. CBD Hemp Product Revenues Predicted to Surge Over the Next Few Years PRNewswireJul 23, 2019
CV Sciences, Inc. to Announce Second Quarter 2019 Results on August 6, 2019 Globe NewswireJul 23, 2019
CV Sciences, Inc. Expands Operations with New Production and Warehousing Facility to Support Worldwide Growth Opportunities Globe NewswireJul 16, 2019
CV Sciences, Inc. Announces Commitment to More Than 500 Acres of U.S. Hemp Production for 2019 Globe NewswireJul 10, 2019
CBD Retail Boom Expands With The Kroger Co. PRNewswireJun 25, 2019
Retailers are Racing to Meet Sizable Worldwide Demand for CBD PRNewswireJun 19, 2019
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

Piper sees 36% upside in Cronos Group in premarket analyst action Seeking Alpha4 days ago
Weekly Cannabis Report: Stock Picking Will Be Key Seeking Alpha5 days ago
CV Sciences, Inc. (CVSI) CEO Joseph Dowling on Q2 2019 Results - Earnings Call Transcript Seeking AlphaAug 06, 2019
CV Sciences EPS in-line, misses on revenue Seeking AlphaAug 06, 2019
Weekly Cannabis Report: Aphria Delivered The Unexpected Seeking AlphaAug 05, 2019
CV Sciences, Inc. Applauds Ohio's State Law Passage of Senate Bill 57 GuruFocusJul 30, 2019
5 Reasons To Invest In The CBD Industry Seeking AlphaJul 30, 2019
CV Sciences, Inc. (CVSI) Reports Next Week: What to Expect ZacksJul 30, 2019
Cannabis Sector Outlook 2H 2019 Seeking AlphaJul 25, 2019
CV Sciences, Inc. to Announce Second Quarter —…–9 Results on August 6, —…–9 GuruFocusJul 23, 2019
{{ story.title }} {{ story.author }}{{ story.created }}

Show more Loading articles...

CVSI $3.19 -0.005 (-0.16%)

CVSI is down -0.005 today, but where's it headed in August?

Zacks Investment Research is releasing its prediction for CVSI based on the 1-3 month trading system that more than doubles the S&P 500. This report is free today for Benzinga readers. Click here - the CVSI analysis is free »

Earnings View Earnings

Q2 2019	EST	Actual	Surprise
EPS:	0.020	0.030	0.0100
Rev:	17.45M	16.85M	-596.00K

Q3 2019	EST	Actual	Surprise
EPS:	Expected 2019-11-07
Rev:	Expected 2019-11-07

Fastest Market News Application
You'll Hear It First On Pro

Company Profile

Visit company website

Brokerage Center

Compare All Online Brokerages

Market Overview

CV SCIENCES INC by CV Sciences, Inc. CVSI:OTCQB OTCQB
Early-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process.

Analyst Rating View All Ratings

Earnings View Earnings

Company Profile

Brokerage Center

Popular Channels

Tools & Features

About Benzinga

Benzinga Partners

Membership is Free

What are you waiting for? Sign up now!

Free Account Login

Market Overview

Tickers

Articles

Keywords

CV SCIENCES INC by CV Sciences, Inc. CVSI:OTCQB OTCQBEarly-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process.

Analyst Rating View All Ratings

Earnings View Earnings

Company Profile

Brokerage Center

Popular Channels

Tools & Features

About Benzinga

Benzinga Partners

CV SCIENCES INC by CV Sciences, Inc. CVSI:OTCQB OTCQB
Early-stage and developing companies that are current in their reporting and undergo an annual verification and management certification process.